Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enisamium Inhibits SARS-CoV-2 RNA Synthesis.
Elli S, Bojkova D, Bechtel M, Vial T, Boltz D, Muzzio M, Peng X, Sala F, Cosentino C, Goy A, Guerrini M, Müller L, Cinatl J, Margitich V, Te Velthuis AJW. Elli S, et al. Among authors: cinatl j. Biomedicines. 2021 Sep 17;9(9):1254. doi: 10.3390/biomedicines9091254. Biomedicines. 2021. PMID: 34572438 Free PMC article.
Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial.
Holubovska O, Bojkova D, Elli S, Bechtel M, Boltz D, Muzzio M, Peng X, Sala F, Cosentino C, Mironenko A, Milde J, Lebed Y, Stammer H, Goy A, Guerrini M, Mueller L, Cinatl J, Margitich V, Te Velthuis AJW. Holubovska O, et al. Among authors: cinatl j. medRxiv [Preprint]. 2021 Jan 21:2021.01.05.21249237. doi: 10.1101/2021.01.05.21249237. medRxiv. 2021. Update in: Biomedicines. 2021 Sep 17;9(9):1254. doi: 10.3390/biomedicines9091254 PMID: 33469600 Free PMC article. Updated. Preprint.
Aprotinin Inhibits SARS-CoV-2 Replication.
Bojkova D, Bechtel M, McLaughlin KM, McGreig JE, Klann K, Bellinghausen C, Rohde G, Jonigk D, Braubach P, Ciesek S, Münch C, Wass MN, Michaelis M, Cinatl J Jr. Bojkova D, et al. Among authors: cinatl j jr. Cells. 2020 Oct 30;9(11):2377. doi: 10.3390/cells9112377. Cells. 2020. PMID: 33143316 Free PMC article.
Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy.
Bojkova D, Costa R, Reus P, Bechtel M, Jaboreck MC, Olmer R, Martin U, Ciesek S, Michaelis M, Cinatl J Jr. Bojkova D, et al. Among authors: cinatl j jr. Metabolites. 2021 Oct 13;11(10):699. doi: 10.3390/metabo11100699. Metabolites. 2021. PMID: 34677415 Free PMC article.
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
Bojkova D, Klann K, Koch B, Widera M, Krause D, Ciesek S, Cinatl J, Münch C. Bojkova D, et al. Among authors: cinatl j. Nature. 2020 Jul;583(7816):469-472. doi: 10.1038/s41586-020-2332-7. Epub 2020 May 14. Nature. 2020. PMID: 32408336 Free PMC article.
Lack of antiviral activity of darunavir against SARS-CoV-2.
De Meyer S, Bojkova D, Cinatl J, Van Damme E, Buyck C, Van Loock M, Woodfall B, Ciesek S. De Meyer S, et al. Among authors: cinatl j. Int J Infect Dis. 2020 Aug;97:7-10. doi: 10.1016/j.ijid.2020.05.085. Epub 2020 May 29. Int J Infect Dis. 2020. PMID: 32479865 Free PMC article.
465 results